Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription Articles published in Curr Opin Immunol Retrieve available abstracts of 68 articles: HTML format

Single Articles

September 2026
1. MERONI PL
   Editorial overview: Editorial introduction - Anti-phospholipid antibody syndrome (2025).
   Curr Opin Immunol. 2026;103:102850.
   PubMed    
   
   
   
2. MOUTSOPOULOS HM
   Autoimmune diseases: distinct disorders or diverse manifestations of a common pathogenic process?
   Curr Opin Immunol. 2026;103:102852.
   PubMed     Abstract available
   
   
   
3. ZIMMERMANN DM, Diamantino D, Andrade SO, Julio PR, et al
   The gastrointestinal pathway leading to autoimmune diseases.
   Curr Opin Immunol. 2026;103:102856.
   PubMed     Abstract available
   
   
   
4. BERTOLACCINI ML, Sanna G
   Clinical relevance of antiphosphatidylserine/prothrombin antibodies in antiphospholipid syndrome.
   Curr Opin Immunol. 2026;103:102842.
   PubMed     Abstract available
   
   
   
5. ROSSANO M, Baldo F, Vaienna P, Lanni S, et al
   A systematic review of juvenile dermatomyositis complicated by macrophage activation syndrome.
   Curr Opin Immunol. 2026;103:102834.
   PubMed     Abstract available
   
   
   August 2026
6. BORGHI MO, Raschi E, Bodio C, Da Via A, et al
   Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.
   Curr Opin Immunol. 2026;101:102805.
   PubMed     Abstract available
   
   
   July 2026
7. MERCADO-CELIN MJ, Patino-Arboleda M, Rios-Serna LJ, Bedoya-Duque MA, et al
   Human endogenous retroviruses leading to autoimmune diseases.
   Curr Opin Immunol. 2026;102:102828.
   PubMed     Abstract available
   
   
   
8. MOUTSOPOULOS HM
   The epithelial cell in Sjogren's syndrome: from passive target to orchestrator of autoimmune reactivity.
   Curr Opin Immunol. 2026;102:102815.
   PubMed     Abstract available
   
   
   
9. LERNER A, Benzvi C
   The food additive microbial transglutaminase is a potential new environmental inducer of autoimmune diseases.
   Curr Opin Immunol. 2026;101:102812.
   PubMed     Abstract available
   
   
   June 2026
10. MOUTSOPOULOS HM, Cinoku II, Mavragani CP
    Raynaud's phenomenon: a vascular or an autoimmune-mediated disorder? Facts and fancy.
    Curr Opin Immunol. 2026;101:102803.
    PubMed     Abstract available
    
    
    
11. TONUTTI A, D'Amico S, Timilsina S, Gershwin ME, et al
    Use of synthetic data, a novel paradigm for immunopathology.
    Curr Opin Immunol. 2026;100:102753.
    PubMed     Abstract available
    
    
    
12. PERICLEOUS C, Strauss E, Arachchillage DJ
    Endothelial dysfunction in APS: advancing pathophysiological understanding to improve management.
    Curr Opin Immunol. 2026;100:102745.
    PubMed     Abstract available
    
    
    May 2026
13. CAMERA M, Tremoli E, Lonati PA, Meroni PL, et al
    Novel mechanisms linking platelet activation to antiphospholipid syndrome.
    Curr Opin Immunol. 2026;101:102791.
    PubMed     Abstract available
    
    
    
14. ARACHCHILLAGE DJ, Efthymiou M, Cohen H
    The role of different aPL subpopulations in the lupus anticoagulant phenomenon.
    Curr Opin Immunol. 2026;100:102784.
    PubMed     Abstract available
    
    
    April 2026
15. SURESH SC, Furie R, Narain S
    Outcome measures in systemic lupus erythematosus.
    Curr Opin Immunol. 2026;100:102782.
    PubMed     Abstract available
    
    
    
16. SEVIM E, Erton ZB, Erkan D
    Understanding antiphospholipid syndrome clinical phenotypes with the guidance of antiphospholipid antibody-related pathogenic mechanisms.
    Curr Opin Immunol. 2026;100:102770.
    PubMed     Abstract available
    
    
    
17. FUJIEDA Y, Amengual O, Meroni PL, Atsumi T, et al
    Hot topics in the antiphospholipid syndrome.
    Curr Opin Immunol. 2026;100:102775.
    PubMed     Abstract available
    
    
    
18. KIROU KA, Kirou RA, Flouda S
    New developments and future directions in the management of systemic lupus erythematosus.
    Curr Opin Immunol. 2026;100:102774.
    PubMed     Abstract available
    
    
    
19. MARTINEZ T, Grand Z, Garcia S, Rockwell M, et al
    A global perspective on autoimmunity and immunodeficiency: exploring geoepidemiology trends.
    Curr Opin Immunol. 2026;100:102773.
    PubMed     Abstract available
    
    
    
20. KUMAR S, Ponzar N, Pozzi N
    beta(2)-Glycoprotein I: structure, mechanisms of autoantibody recognition, and polymorphisms.
    Curr Opin Immunol. 2026;100:102771.
    PubMed     Abstract available
    
    
    
21. KIRINO Y, Takeno M
    A critical look at animal and cellular models in autoinflammatory diseases.
    Curr Opin Immunol. 2026;99:102719.
    PubMed     Abstract available
    
    
    March 2026
22. MATHEOUD D, Akbar I, Hercun J, Stratton JA, et al
    A liver-mitochondria-immune axis in Parkinson's disease: emerging perspectives on a hepatic origin for mitochondrial autoimmunity as a driver of Parkinson's disease.
    Curr Opin Immunol. 2026;100:102761.
    PubMed     Abstract available
    
    
    
23. YALAVARTHI S, NaveenKumar SK, Knight JS
    Neutrophils and monocytes in the pathogenesis of antiphospholipid syndrome.
    Curr Opin Immunol. 2026;100:102768.
    PubMed     Abstract available
    
    
    
24. RENAUDINEAU Y, Brooks W
    P2 purinergic receptors in systemic lupus erythematosus: from experimental findings to therapeutic perspectives.
    Curr Opin Immunol. 2026;100:102752.
    PubMed     Abstract available
    
    
    
25. GROSSI C, Buckle II, McDonnell TC
    Autoimmunity beyond antibodies: alternative roles of beta-2-glycoprotein I in and out of antiphospholipid syndrome?
    Curr Opin Immunol. 2026;100:102748.
    PubMed     Abstract available
    
    
    February 2026
26. JULIAN VELASCO-LANCHEROS O, Acosta-Ampudia Y, Monsalve DM, Ramirez-Santana C, et al
    Mpox virus immunology: exploring links to autoimmune diseases.
    Curr Opin Immunol. 2026;99:102744.
    PubMed     Abstract available
    
    
    
27. ALTINTAS A, Bulus E
    Multiple sclerosis: a disease or a syndrome?
    Curr Opin Immunol. 2026;99:102736.
    PubMed     Abstract available
    
    
    
28. MEGHASHYAM S, Serajee FJ, Prakash AV, Altinok D, et al
    Primary angiitis of the central nervous system.
    Curr Opin Immunol. 2026;98:102691.
    PubMed     Abstract available
    
    
    January 2026
29. ELSAGHIR A, Witte T
    New autoantibodies in Sjogren's disease.
    Curr Opin Immunol. 2026;99:102722.
    PubMed     Abstract available
    
    
    December 2025
30. YANG T, Goudarzi N, Kroese FGM, Mariette X, et al
    Salivary gland organoids and the future of modeling autoimmune epithelitis in Sjogren's disease.
    Curr Opin Immunol. 2025;98:102707.
    PubMed     Abstract available
    
    
    November 2025
31. SWEENEY N, Atisha-Fregoso Y, Pozovskiy R, Higdon L, et al
    Can we cure autoimmunity?
    Curr Opin Immunol. 2025;98:102684.
    PubMed     Abstract available
    
    
    October 2025
32. ROJAS M, Acosta-Ampudia Y, Monsalve DM, Rami?rez-Santana C, et al
    Autoimmunity, epitope analysis, and molecular mimicry.
    Curr Opin Immunol. 2025;97:102681.
    PubMed     Abstract available
    
    
    
33. CLEMENT TL, Cohen PL
    Can we cure lupus?
    Curr Opin Immunol. 2025;96:102640.
    PubMed     Abstract available
    
    
    
34. MAHARAJ S, Chang C
    Can juvenile idiopathic arthritis be cured?
    Curr Opin Immunol. 2025;96:102632.
    PubMed     Abstract available
    
    
    
35. SULLIVAN JK, Kwun A, Jorgensen TN
    Neuropsychiatric lupus: a myriad of symptoms requires a myriad of models.
    Curr Opin Immunol. 2025;96:102631.
    PubMed     Abstract available
    
    
    
36. FREE ME, Ciavatta DJ, Falk RJ
    Can we cure vasculitis?
    Curr Opin Immunol. 2025;96:102618.
    PubMed     Abstract available
    
    
    September 2025
37. CLAVARINO G, Vigne J, Meuleman MS, Amen A, et al
    Complement in systemic lupus erythematosus across time and space: from tolerance to tissue injury and from extracellular to intracellular functions.
    Curr Opin Immunol. 2025;97:102655.
    PubMed     Abstract available
    
    
    August 2025
38. MOSELEY CE, Sabatino JJ Jr, Zamvil SS
    B-cell antigen presentation in central nervous system autoimmunity.
    Curr Opin Immunol. 2025;96:102647.
    PubMed     Abstract available
    
    
    
39. HU Z, Zhao M
    B cell-targeted therapies in autoimmune skin disease: current advances and challenges.
    Curr Opin Immunol. 2025;96:102643.
    PubMed     Abstract available
    
    
    
40. DRAGON DUREY MA, Hamidi H, Darnige L
    Complement in antiphospholipid syndrome, time to target?
    Curr Opin Immunol. 2025;96:102628.
    PubMed     Abstract available
    
    
    
41. MERONI PL, Capobianco E, Tedesco F
    Can we cure antiphospholipid syndrome?
    Curr Opin Immunol. 2025;96:102610.
    PubMed     Abstract available
    
    
    
42. CETIN GEDIK K, Casares-Marfil D, Demirkaya E, Sawalha AH, et al
    The role of epigenetic modifications in systemic autoinflammatory diseases.
    Curr Opin Immunol. 2025;95:102599.
    PubMed     Abstract available
    
    
    
43. XU C, Shen Y, Wang Q, Zhu H, et al
    Immunotherapy for pemphigus and bullous pemphigoid.
    Curr Opin Immunol. 2025;95:102591.
    PubMed     Abstract available
    
    
    
44. LIU S, Lu Q
    Can we cure bullous skin diseases?
    Curr Opin Immunol. 2025;95:102589.
    PubMed     Abstract available
    
    
    
45. OKAZAKI K, Ikeura T, Uchida K
    'Can we cure IgG4-related diseases?'.
    Curr Opin Immunol. 2025;95:102564.
    PubMed     Abstract available
    
    
    July 2025
46. LIN SL, Carroll MC
    Neuroimmune mechanisms of neuropsychiatric systemic lupus erythematosus.
    Curr Opin Immunol. 2025;96:102608.
    PubMed     Abstract available
    
    
    
47. LONGHI MS, Zhang L, Mieli-Vergani G, Vergani D, et al
    Can we cure autoimmune hepatitis?
    Curr Opin Immunol. 2025;96:102609.
    PubMed     Abstract available
    
    
    
48. DEI ZOTTI F, Hudson KE
    Development and consequences of red blood cell autoantibodies: warm autoimmune hemolytic anemia.
    Curr Opin Immunol. 2025;95:102604.
    PubMed     Abstract available
    
    
    
49. FAN S, Pruss H
    Pathogenic mechanisms of autoantibodies in neurological autoimmune diseases.
    Curr Opin Immunol. 2025;95:102594.
    PubMed     Abstract available
    
    
    
50. XU Y, Yi X, Li C, Chen J, et al
    CD8(+)T cell exhaustion: the potential for treating autoimmune diseases.
    Curr Opin Immunol. 2025;95:102600.
    PubMed     Abstract available
    
    
    June 2025
51. NIE W, Yang X, Ma M, Xu X, et al
    Chimeric antigen receptor T cell therapy for autoimmune diseases.
    Curr Opin Immunol. 2025;95:102596.
    PubMed     Abstract available
    
    
    
52. DAI M, Mei B, Zheng F, Ballestar E, et al
    Sex hormones and epigenetic dysregulation in autoimmune disease.
    Curr Opin Immunol. 2025;95:102595.
    PubMed     Abstract available
    
    
    
53. ZHOU W, Zhang B, Zhao M, Lu Q, et al
    Epigenetics: the link between environmental exposures and autoimmune diseases.
    Curr Opin Immunol. 2025;95:102592.
    PubMed     Abstract available
    
    
    
54. MAUDES E, Planaguma J, Weber MS, Dalmau J, et al
    Animal models of autoimmune encephalitis.
    Curr Opin Immunol. 2025;95:102579.
    PubMed     Abstract available
    
    
    
55. GUVENC F, Danska JS
    The intestinal microbiome in type 1 diabetes: bridging early childhood exposures with translational advances.
    Curr Opin Immunol. 2025;94:102553.
    PubMed     Abstract available
    
    
    May 2025
56. CHEN J, Wang X
    Epigenetic regulation of B cell response in autoimmune diseases.
    Curr Opin Immunol. 2025;95:102582.
    PubMed     Abstract available
    
    
    
57. LE PANSE R
    Is there a path to cure myasthenia gravis?
    Curr Opin Immunol. 2025;95:102577.
    PubMed     Abstract available
    
    
    
58. KOLEV M, Kremer AE, Sokollik C, Gershwin ME, et al
    Unmet needs in autoimmune liver diseases.
    Curr Opin Immunol. 2025;95:102565.
    PubMed     Abstract available
    
    
    April 2025
59. TAYLOR H, Uhlig HH, Powrie F
    Autoimmunity in inflammatory bowel disease: a holobiont perspective.
    Curr Opin Immunol. 2025;94:102557.
    PubMed     Abstract available
    
    
    
60. SUN Y, Zhang Z, Jia K, Liu H, et al
    Autoimmune-related adverse events induced by immune checkpoint inhibitors.
    Curr Opin Immunol. 2025;94:102556.
    PubMed     Abstract available
    
    
    
61. SAVVIDES CS, James EA, Buckner JH
    Rheumatoid arthritis - the role of T cells in this complex systemic autoimmune disease.
    Curr Opin Immunol. 2025;94:102555.
    PubMed     Abstract available
    
    
    
62. WRIGHT RC, Campbell DJ, Levings MK
    Pharmacotherapeutic strategies to promote regulatory T cell function in autoimmunity.
    Curr Opin Immunol. 2025;94:102554.
    PubMed     Abstract available
    
    
    
63. LOVELL CD, Anguera MC
    More X's, more problems: how contributions from the X chromosomes enhance female predisposition for autoimmunity.
    Curr Opin Immunol. 2025;93:102543.
    PubMed     Abstract available
    
    
    
64. KRONENBERG M, Riffelmacher T
    Defenders or defectors: mucosal-associated invariant T cells in autoimmune diseases.
    Curr Opin Immunol. 2025;93:102542.
    PubMed     Abstract available
    
    
    
65. SOWERBY JM, Rao DA
    T cell-B cell interactions in human autoimmune diseases.
    Curr Opin Immunol. 2025;93:102539.
    PubMed     Abstract available
    
    
    January 2025
66. HAO K, Marshak-Rothstein A
    Nucleic acid triggers of autoimmunity and autoinflammation.
    Curr Opin Immunol. 2025;93:102535.
    PubMed     Abstract available
    
    
    December 2024
67. HARM J, Fan YT, Brenner D
    Navigating the metabolic landscape of regulatory T cells: from autoimmune diseases to tumor microenvironments.
    Curr Opin Immunol. 2024;92:102511.
    PubMed     Abstract available
    
    
    September 2024
68. HAMERMAN JA, Barton GM
    The path ahead for understanding Toll-like receptors-driven systemic autoimmunity.
    Curr Opin Immunol. 2024;91:102482.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum